{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:44:26Z","timestamp":1791881066088,"version":"4.3.4"},"reference-count":113,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The thiazole nucleus serves as a bioactive synthetic scaffold in drug design and discovery due to its diverse pharmacological activities. It was discovered that many types of thiazole derivatives, including those with one, two, or three substitutions, five- or six-membered heterocycles, fused rings, and thiazole-derived Schiff bases, hydrazinyl derivatives, amides, chalcones, and bis-thiazoles, can fight cancer. Thus, the structural diversity of thiazole nuclei makes it one of the significant areas of research in the pharmaceutical field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>We would like to elaborate on the recent literature available on the antiproliferative property of molecules bearing 1,3-thiazole nuclei.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This review summarises the anticancer potency of thiazole derivatives collected from recently available scientific literature. We extracted the information from online data-bases like PubMed, Scopus, and Web of Science using relevant keywords from 2016 to the present. We discuss the current state of thiazole derivatives and highlight the most promising compounds. We also describe how they work and what their half-maximum inhibitory con-centration (IC50) is.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Based on our extensive literature review, we found that thiazole derivatives exhibit anticancer activity through their ability to induce apoptosis in cancer cells, mitochondrial membrane disruption by blocking signalling pathways such as Akt, NFkB, PI3K, and Src\/Abl, and inhibition of proteins responsible for cell growth. Moreover, thiazole-protein interactions essential for cancer inhibition are predominantly regulated by hydrogen bonding, supported by the sulphur and nitrogen atoms in the thiazole molecule, which effectively interacts with the amino acids serine, tyrosine, and glutamine. \u03c0\u2013\u03c0 stacking and \u03c0\u2013cation interactions involv-ing aromatic amino acids such as tryptophan, tyrosine, and phenylalanine, along with hydro-phobic effects and van der Waals forces, play a crucial role in thiazole\u2013protein interactions. These interactions dictate binding affinity and efficacy, measured through thermodynamic characteristics such as Binding Constant (Kb), Dissociation Constant (Kd), and Gibbs free energy (\u0394G). Comprehending these features is essential for the development of effective thia-zole-based anticancer pharmaceuticals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This cumulative information is enough to give new ideas for the rational drug design of thiazole-based derivatives and could be pursued as a promising lead in the future for the management of cancer threats.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115680096375796250610065705","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T02:07:55Z","timestamp":1750990075000},"page":"1113-1129","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the Therapeutic Potential of Compounds Carrying Mono- and Bis-Thiazole Nuclei with Distinct Heterocyclic Analogues for Addressing Cancer Challenges"],"prefix":"10.2174","volume":"26","author":[{"given":"Thangavelu","family":"Saravanan","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, Government Medical College and Hospital, Pudukkottai, 622004, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chellappa","family":"Selvinthanuja","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Nandha College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Chennai, Erode, 638052, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvaraj","family":"Jubie","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education &amp; Research, Ooty, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Kathiravan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, 603203, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramasamy","family":"Thilagavathi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Ennam College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Chennai, Coimbatore, 641032, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerasamy","family":"Ravichandran","sequence":"additional","affiliation":[{"name":"Pharmaceutical Chemistry Unit, Faculty of Pharmacy, AIMST University, JalanBedong-Semeling, 08100, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thangavelu","family":"Prabha","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Nandha College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Chennai, Erode, 638052, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ejmech.2017.05.023","volume":"136","author":"de Oliveira J.F.","year":"2017","unstructured":"de Oliveira J.F.; Lima T.S.; Vendramini-Costa D.B.; de Lacerda Pedrosa S.C.B.; Lafayette E.A.; da Silva R.M.F.; de Almeida S.M.V.; de Moura R.O.; Ruiz A.L.T.G.; de Carvalho J.E.; de Lima M.C.A.; Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay. Eur J Med Chem  2017,136,305-314","journal-title":"Eur J Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0140-6736(20)30164-1","volume":"395","author":"Bedard P.L.","year":"2020","unstructured":"Bedard P.L.; Hyman D.M.; Davids M.S.; Siu L.L.; Small molecules, big impact: 20 years of targeted therapy in oncology. Lancet  2020,395(10229),1078-1088","journal-title":"Lancet"},{"key":"ref=3","first-page":"281","volume":"7","author":"Ghasemi B.","year":"2015","unstructured":"Ghasemi B.; Sanjarani G.; Sanjarani Z.; Majidiani H.; Evaluation of anti-bacterial effects of some novel thiazole and imidazole derivatives against some pathogenic bacteria. Iran J Microbiol  2015,7(5),281-286","journal-title":"Iran J Microbiol"},{"key":"ref=4","first-page":"65","volume":"7","author":"Khabnadideh S.","year":"2012","unstructured":"Khabnadideh S.; Rezaei Z.; Pakshir K.; Zomorodian K.; Ghafari N.; Synthesis and antifungal activity of benzimidazole, benzotriazole and aminothiazole derivatives. Res Pharm Sci  2012,7(2),65-72","journal-title":"Res Pharm Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"127655","DOI":"10.1016\/j.bmcl.2020.127655","volume":"30","author":"Cordeiro R.","year":"2020","unstructured":"Cordeiro R.; Kachroo M.; Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles. Bioorg Med Chem Lett  2020,30(24),127655","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00044-017-1963-1","volume":"26","author":"Madni M.","year":"2017","unstructured":"Madni M.; Hameed S.; Ahmed M.N.; Tahir M.N.; Al-Masoudi N.A.; Pannecouque C.; Synthesis, crystal structure, anti-HIV, and antiproliferative activity of new pyrazolylthiazole derivatives. Med Chem Res  2017,26(10),2653-2665","journal-title":"Med Chem Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2174\/1573407215666190308154139","volume":"16","author":"Das A.","year":"2020","unstructured":"Das A.; Ghosh S.K.; Bhat H.R.; Kalita J.; Kashyap A.; Adhikari N.; Docking, synthesis and antimalarial evaluation of hybrid phenyl thiazole 1, 3, 5-triazine derivatives. Curr Bioact Compd  2020,16(5),639-653","journal-title":"Curr Bioact Compd"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/14756360903555258","volume":"26","author":"Amnerkar N.D.","year":"2011","unstructured":"Amnerkar N.D.; Bhusari K.P.; Synthesis of some thiazolyl aminobenzothiazole derivatives as potential antibacterial, antifungal and anthelmintic agents. J Enzyme Inhib Med Chem  2011,26(1),22-28","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ejmech.2013.04.005","volume":"65","author":"Helal M.H.M.","year":"2013","unstructured":"Helal M.H.M.; Salem M.A.; El-Gaby M.S.A.; Aljahdali M.; Synthesis and biological evaluation of some novel thiazole compounds as potential anti-inflammatory agents. Eur J Med Chem  2013,65,517-526","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e18218","DOI":"10.1590\/s2175-97902019000118218","volume":"55","author":"Resende M.F.","year":"2019","unstructured":"Resende M.F.; Lino C.I.; Souza-Fagundes E.M.; Rettore J.V.P.; Oliveira R.B.; Labanca R.A.; Assessment of anti-diabetic activity of a novel hydrazine-thiazole derivative: in vitro and in vivo method. Braz J Pharm Sci  2019,55,e18218","journal-title":"Braz J Pharm Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1002\/slct.201900646","volume":"4","author":"Khamees H.A.","year":"2019","unstructured":"Khamees H.A.; Mohammed Y.H.E.; Swamynayaka A.; Al-Ostoot F.H.; Sert Y.; Alghamdi S.; Khanum S.A.; Madegowda M.; Molecular structure, DFT, vibrational spectra with fluorescence effect, hirshfeld surface, docking simulation and antioxidant activity of thiazole derivative. ChemistrySelect  2019,4(15),4544-4558","journal-title":"ChemistrySelect"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1007\/s00044-015-1371-3","volume":"24","author":"Ghabbour H.A.","year":"2015","unstructured":"Ghabbour H.A.; Kadi A.A.; ElTahir K.E.H.; Angawi R.F.; El-Subbagh H.I.; Synthesis, biological evaluation and molecular docking studies of thiazole-based pyrrolidinones and isoindolinediones as anticonvulsant agents. Med Chem Res  2015,24(8),3194-3211","journal-title":"Med Chem Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.3390\/molecules27196138","volume":"27","author":"Raghunatha P.","year":"2022","unstructured":"Raghunatha P.; Inamdar M.N.; Asdaq S.M.B.; Almuqbil M.; Alzahrani A.R.; Alaqel S.I.; Kamal M.; Alsubaie F.H.; Alsanie W.F.; Alamri A.S.; Rabbani S.I.; Attimarad M.; Mohan S.; Alhomrani M.; New thiazole acetic acid derivatives: A study to screen cardiovascular activity using isolated rat hearts and blood vessels. Molecules  2022,27(19),6138","journal-title":"Molecules"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/2589977512666200824103019","volume":"13","author":"Selvaraj J.","year":"2021","unstructured":"Selvaraj J.; Prabha T.; Yadav N.; Identification of drug candidates for breast cancer therapy through scaffold repurposing: a brief review, current drug research reviews formerly. Curr Drug Res Rev  2021,13(1),3-15","journal-title":"Curr Drug Res Rev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1200\/JCO.2004.12.001","volume":"22","author":"Goodin S.","year":"2004","unstructured":"Goodin S.; Kane M.P.; Rubin E.H.; Epothilones: mechanism of action and biologic activity. J Clin Oncol  2004,22(10),2015-2025","journal-title":"J Clin Oncol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2146\/ajhp070628","volume":"65","author":"Goodin S.","year":"2008","unstructured":"Goodin S.; Ixabepilone: A novel microtubule-stabilizing agent for the treatment of metastatic breast cancer. Am J Health Syst Pharm  2008,65(21),2017-2026","journal-title":"Am J Health Syst Pharm"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1016\/j.bmcl.2006.02.001","volume":"16","author":"Popsavin M.","year":"2006","unstructured":"Popsavin M.; Torovi\u0107 L.; Svir\u010dev M.; Koji\u0107 V.; Bogdanovi\u0107 G.; Popsavin V.; Synthesis and antiproliferative activity of two new tiazofurin analogues with 2\u2032-amido functionalities. Bioorg Med Chem Lett  2006,16(10),2773-2776","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1517\/17425255.2013.794220","volume":"9","author":"Gibney G.T.","year":"2013","unstructured":"Gibney G.T.; Zager J.S.; Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies. Expert Opin Drug Metab Toxicol  2013,9(7),893-899","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1124\/dmd.108.025932","volume":"37","author":"Li X.","year":"2009","unstructured":"Li X.; He Y.; Ruiz C.H.; Koenig M.; Cameron M.D.; Vojkovsky T.; Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways. Drug Metab Dispos  2009,37(6),1242-1250","journal-title":"Drug Metab Dispos"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"eabg0809","DOI":"10.1126\/scitranslmed.abg0809","volume":"13","author":"Delestre F.","year":"2021","unstructured":"Delestre F.; Venot Q.; Bayard C.; Fraissenon A.; Ladraa S.; Hoguin C.; Chapelle C.; Yamaguchi J.; Cassaca R.; Zerbib L.; Magassa S.; Morin G.; Asnafi V.; Villarese P.; Kaltenbach S.; Fraitag S.; Duong J.P.; Broissand C.; Boccara O.; Soupre V.; Bonnotte B.; Chopinet C.; Mirault T.; Legendre C.; Guibaud L.; Canaud G.; Alpelisib administration reduced lymphatic malformations in a mouse model and in patients. Sci Transl Med  2021,13(614),eabg0809","journal-title":"Sci Transl Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1080\/00397911.2021.1884262","volume":"51","author":"Kesari C.","year":"2021","unstructured":"Kesari C.; Rama K.R.; Sedighi K.; Stenvang J.; Bj\u00f6rkling F.; Kankala S.; Thota N.; Synthesis of thiazole linked chalcones and their pyrimidine analogues as anticancer agents. Synth Commun  2021,51(9),1406-1416","journal-title":"Synth Commun"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"103761","DOI":"10.1016\/j.bioorg.2020.103761","volume":"98","author":"Farghaly T.A.","year":"2020","unstructured":"Farghaly T.A.; Masaret G.S.; Muhammad Z.A.; Harras M.F.; Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity. Bioorg Chem  2020,98,103761","journal-title":"Bioorg Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/molecules27031009","volume":"27","author":"Liu J.C.","year":"2022","unstructured":"Liu J.C.; Chen B.; Yang J.L.; Weng J.Q.; Yu Q.; Hu D.X.; Design, synthesis and cytotoxicity of thiazole-based stilbene analogs as novel DNA topoisomerase IB inhibitors. Molecules  2022,27(3),1009","journal-title":"Molecules"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13065-019-0575-x","volume":"13","author":"Sharma D.","year":"2019","unstructured":"Sharma D.; Kumar S.; Narasimhan B.; Ramasamy K.; Lim S.M.; Shah S.A.A.; Mani V.; 4-(4-Bromophenyl)-thiazol-2-amine derivatives: synthesis, biological activity and molecular docking study with ADME profile. BMC Chem  2019,13(1),60","journal-title":"BMC Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bjbas.2016.01.001","volume":"5","author":"Mookhles M.","year":"2016","unstructured":"Mookhles M.; Synthesis, anticancer activity and molecular docking study of Schiff base complexes containing thiazole moiety. Beni Suef Uni J Bas App Sci  2016,5(1),85-96","journal-title":"Beni Suef Uni J Bas App Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2174\/1570180814666161104161711","volume":"14","author":"Kaplanc\u0131kl\u0131 Z.A.","year":"2017","unstructured":"Kaplanc\u0131kl\u0131 Z.A.; Sever B.; Alt\u0131ntop M.D.; Atl\u0131 O.; Baysal M.; Ozdemir A.; Synthesis and evaluation of new thiazolyl hydrazine derivatives as potential anticancer agents. Lett Drug Des Discov  2017,14(6),672-677","journal-title":"Lett Drug Des Discov"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/13543784.2019.1676726","volume":"28","author":"Shariati M.","year":"2019","unstructured":"Shariati M.; Meric-Bernstam F.; Targeting AKT for cancer therapy. Expert Opin Investig Drugs  2019,28(11),977-988","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/molecules23061318","volume":"23","author":"Alt\u0131ntop M.D.","year":"2018","unstructured":"Alt\u0131ntop M.D.; Sever B.; Akal\u0131n \u00c7ift\u00e7i G.; \u00d6zdemir A.; Design, synthesis and evaluation of a new series of thiazole-based anticancer agents as potent Akt inhibitors. Molecules  2018,23(6),1318","journal-title":"Molecules"},{"key":"ref=29","first-page":"874","volume":"20","author":"Italo da Santana T.","year":"2018","unstructured":"Italo da Santana T.; Miria de Oliveira B.; Synthesis, anticancer activity and mechanism of action of new thiazole derivatives. Eur J Med Chem  2018,20(144),874-886","journal-title":"Eur J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bioorg.2018.12.010","volume":"84","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Wu C.; Zhang Q.; Shan Y.; Gu W.; Wang S.; Design, synthesis and biological evaluation of novel \u03b2-pinene-based thiazole derivatives as potential anticancer agents via mitochondrial-mediated apoptosis pathway. Bioorg Chem  2019,84,468-477","journal-title":"Bioorg Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.2174\/092986710793213724","volume":"17","author":"Zitka O.","year":"2010","unstructured":"Zitka O.; Kukacka J.; Krizkov S.; Huska D.; Adam V.; Masarik M.; Prusa R.; Kizek R.; Matrix Metalloproteinases. Curr Med Chem  2010,17(31),3751-3768","journal-title":"Curr Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"103992","DOI":"10.1016\/j.bioorg.2020.103992","volume":"101","author":"Omar A.M.","year":"2020","unstructured":"Omar A.M.; Bajorath J.; Ihmaid S.; Mohamed H.M.; El-Agrody A.M.; Mora A.; El-Araby M.E.; Ahmed H.E.A.; Novel molecular discovery of promising amidine-based thiazole analogues as potent dual matrix metalloproteinase-2 and 9 inhibitors: Anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects. Bioorg Chem  2020,101,103992","journal-title":"Bioorg Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/ph16071014","volume":"16","author":"Al-Wahaibi L.H.","year":"2023","unstructured":"Al-Wahaibi L.H.; El-Sheref E.M.; Hassan A.A.; Br\u00e4se S.; Nieger M.; Youssif B.G.M.; Ibrahim M.A.A.; Tawfeek H.N.; Synthesis and structure determination of substituted thiazole derivatives as EGFR\/BRAFV600E dual inhibitors endowed with antiproliferative activity. Pharmaceuticals (Basel)  2023,16(7),1014","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2174\/1389200221666201217094602","volume":"22","author":"Bilal A.","year":"2021","unstructured":"Bilal A.; Anticancer activity and in silico admet properties of 2,4,5-trisubstitutedthiazole derivatives. Curr Drug Metab  2021,22(7),532-536","journal-title":"Curr Drug Metab"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"103188","DOI":"10.1016\/j.bioorg.2019.103188","volume":"92","author":"Sigalapalli D.K.","year":"2019","unstructured":"Sigalapalli D.K.; Pooladanda V.; Singh P.; Kadagathur M.; Guggilapu S.D.; Uppu J.L.; Tangellamudi N.D.; Gangireddy P.K.; Godugu C.; Bathini N.B.; Discovery of certain benzyl\/phenethyl thiazolidinone-indole hybrids as potential anti-proliferative agents: Synthesis, molecular modeling and tubulin polymerization inhibition study. Bioorg Chem  2019,92,103188","journal-title":"Bioorg Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/14756366.2021.1958213","volume":"36","author":"Wang Guangcheng","year":"2021","unstructured":"Wang Guangcheng; Liu Wenjing; Fan Meiyan; He Min; Li Yongjun; Peng Zhiyun Design; synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors. J Enzyme Inhib Med Chem  2021,36(1),1694-1702","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"105015","DOI":"10.1016\/j.bioorg.2021.105015","volume":"114","author":"Dang Xin","year":"2021","unstructured":"Dang Xin; Lei Shuwen; Luo Shuhua; Hu Yixin; Wang Juntao; Zhang Dongdong; Lu Dan; Jiang Faqin; Fu Lei; Design, synthesis and biological evaluation of novel thiazole-derivatives as mitochondrial targeting inhibitors of cancer cells. Bioorg Chem  2021,114,105015","journal-title":"Bioorg Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2478\/pjct-2019-0025","volume":"21","author":"Bakare S.B.","year":"2019","unstructured":"Bakare S.B.; Anticancer activity of some new series of 2-(substituted)amino-1,3-thiazole derivatives. Pol J Chem Technol  2019,21(3),19-25","journal-title":"Pol J Chem Technol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/1570178614666170907122026","volume":"15","author":"Somu C.","year":"2018","unstructured":"Somu C.; Hegde M.; Kothanahally S.; Synthesisand biological evaluation of novel thiazol-2-yl-amine derivatives as potential anticancer agents. Lett Org Chem  2018,15,270-281","journal-title":"Lett Org Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/1752-1947-6-266","volume":"6","author":"Sato T.","year":"2012","unstructured":"Sato T.; Tomaru K.; Koide T.; Masuda M.; Yamamoto M.; Miyazawa N.; Inayama Y.; Kaneko T.; Ishigatsubo Y.; Synchronous lung and gastric cancers successfully treated with carboplatin and pemetrexed: A case report. J Med Case Reports  2012,6(1),266","journal-title":"J Med Case Reports"},{"key":"ref=41","author":"Sun M.","year":"2017","unstructured":"Sun M.; Xu Q.; Xu J.; Wu Y.; Wang Y.; Synthesis and bioevaluation of N,4-diaryl-1,3-thiazole-2-amines as tubulin inhibitors with potent antiproliferative activity. PLoS One  2017","journal-title":"PLoS One"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.21474\/IJAR01\/2347","volume":"4","author":"Aisha Y.","year":"2016","unstructured":"Aisha Y.; Investigations synthesis, characterization and evaluation of the anticancer activity of novel 2-aminophenyl thiazole derivative heterocycles. Int J Adv Res (Indore)  2016,4(11),2359-2375","journal-title":"Int J Adv Res (Indore)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12943-016-0505-7","volume":"15","author":"Thamkachy R.","year":"2016","unstructured":"Thamkachy R.; Kumar R.; ERK mediated upregulation of death receptor 5 overcomes the lack of p53 fuctionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells. Mol Cancer  2016,15,22","journal-title":"Mol Cancer"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.3390\/molecules27154898","volume":"27","author":"Salem M.G.","year":"2022","unstructured":"Salem M.G.; El-Maaty D.M.A.; El-Deen Y.I.M.; Elesawy B.H.; Askary A.E.; Saleh A.; Saied E.M.; Behery M.E.; Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study. Molecules  2022,27(15),4898","journal-title":"Molecules"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"17552","DOI":"10.1021\/acsomega.2c07569","volume":"8","author":"Sharma D.","year":"2023","unstructured":"Sharma D.; Singh M.; Joshi J.; Garg M.; Chaudhary V.; Blankenberg D.; Chandna S.; Kumar V.; Rani R.; Design and Synthesis of Thiazole Scaffold-Based Small Molecules as Anticancer Agents Targeting the Human Lactate Dehydrogenase A Enzyme. ACS Omega  2023,8(20),17552-17562","journal-title":"ACS Omega"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.drudis.2018.05.014","volume":"23","author":"Zhang S.L.","year":"2018","unstructured":"Zhang S.L.; He Y.; Tam K.Y.; Targeting cancer metabolism to develop human lactate dehydrogenase ( h LDH)5 inhibitors. Drug Discov Today  2018,23(7),1407-1415","journal-title":"Drug Discov Today"},{"key":"ref=47","author":"Farghaly T.A.","year":"2019","unstructured":"Farghaly T.A.; El-Metwaly N.; Al-Soliemy A.M.; Katouah H.A.; Synthesis, molecular docking and antitumor activity of new dithiazoles. Polycycl Aromat Compd  2019","journal-title":"Polycycl Aromat Compd"},{"key":"ref=48","first-page":"1","volume":"21","author":"Sobhi M.","year":"2016","unstructured":"Sobhi M.; Synthesis, characterization and molecular docking of novel thiazolyl-thiazole derivatives as promising antitumor drug. Molecules  2016,21(3),1-17","journal-title":"Molecules"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.bbadis.2015.04.003","volume":"1852","author":"P\u00e9rez-Aguilar B.","year":"2015","unstructured":"P\u00e9rez-Aguilar B.; Vidal C.J.; Palomec G.; Garc\u00eda-Dolores F.; Guti\u00e9rrez-Ruiz M.C.; Bucio L.; G\u00f3mez-Olivares J.L.; G\u00f3mez-Quiroz L.E.; Acetylcholinesterase is associated with a decrease in cell proliferation of hepatocellular carcinoma cells. Biochim Biophys Acta Mol Basis Dis  2015,1852(7),1380-1387","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ejmech.2015.11.002","volume":"107","author":"Turan-Zitouni Gulhan","year":"2016","unstructured":"Turan-Zitouni Gulhan; Altintop Mehlika Dilek; Ozdemir Ahmet; Kaplancikli Zafer Asim; Ciftci Gilsen Akalin; Temel Halide Edip; Synthesis and evaluation of bis-thiazole derivatives as new anticancer agents. Eur J Med Chem  2016,107,288-94","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/molecules26102847","volume":"26","author":"Kasetti A.B.","year":"2021","unstructured":"Kasetti A.B.; Singhvi I.; Nagasuri R.; Bhandare R.R.; Shaik A.B.; Thiazole\u2013chalcone hybrids as prospective antitubercular and antiproliferative agents: Design, synthesis, biological, molecular docking studies and in silico ADME evaluation. Molecules  2021,26(10),2847","journal-title":"Molecules"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"8908","DOI":"10.3390\/app11198908","volume":"11","author":"Laila A.","year":"2021","unstructured":"Laila A.; Al-Mutabagani, Fathy M.; Abdelrazek, Sobhi M.; Gomha, Ali S.; Hebishy, Mohamed S.; Abdelfattah, Safaa M.; Hassan, Abdelwahed R.; Sayed, Mahmoud M.; Elaasser. Synthesis and biological evaluation of thiazolyl-Ethylidene Hydrazono-Thiazole derivatives: A novel heterocyclic system. Appl Sci (Basel)  2021,11,8908","journal-title":"Appl Sci (Basel)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1517\/13543784.2012.668527","volume":"21","author":"Merkel A.L.","year":"2012","unstructured":"Merkel A.L.; Meggers E.; Ocker M.; PIM1 kinase as a target for cancer therapy. Expert Opin Investig Drugs  2012,21(4),425-436","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"694870","DOI":"10.3389\/fchem.2021.694870","volume":"9","author":"Dawood K.M.","year":"2021","unstructured":"Dawood K.M.; Raslan M.A.; Abbas A.A.; Mohamed B.E.; Abdellattif M.H.; Nafie M.S.; Hassan M.K.; Novel bis-thiazole derivatives: synthesis and potential cytotoxic activity through apoptosis with molecular docking approaches. Front Chem  2021,9,694870","journal-title":"Front Chem"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/DDDT.S221263","volume":"14","author":"Abdelwahed R.","year":"2020","unstructured":"Abdelwahed R.; One-pot synthesis of novel thiazoles as potential anticancer agents. Drug Des Devel Ther  2020,14,1363-1375","journal-title":"Drug Des Devel Ther"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2166936","DOI":"10.1080\/14756366.2023.2166936","volume":"38","author":"Al-Sanea M.M.","year":"2023","unstructured":"Al-Sanea M.M.; Nasr T.M.; Bondock S.; Gawish A.Y.; Mohamed N.M.; Design, synthesis and cytotoxic evaluation of novel bis-thiazole derivatives as preferential Pim1 kinase inhibitors with in vivo and in silico study. J Enzyme Inhib Med Chem  2023,38(1),2166936","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"604","DOI":"10.17344\/acsi.2020.6446","volume":"68","author":"Amira E.M.","year":"2021","unstructured":"Amira E.M.; Synthesis and anticancer evaluations of novel thiaole derivatives derived from 4-phenylthiazol-2-amine. Acta Chim Slov  2021,68,604-616","journal-title":"Acta Chim Slov"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1080\/10426507.2018.1550642","volume":"194","author":"Asaf E.","year":"2019","unstructured":"Asaf E.; Synthesis and biological evaluation of 5-methyl-4-phenyl thiazole derivatives as anticancer agents. Phosphorus, sulphur and silicon and the related elements  2019,194(8),820-828","journal-title":"Phosphorus, sulphur and silicon and the related elements"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.01.015","author":"Ayati A.","year":"2018","unstructured":"Ayati A.; Esmaeili R.; Moghimi S.; Bakhshaiesh T.O.; Synthesis and biological evaluation of 4-amino-5-cinnamoyl thiazole as chalcone-like anticancer agents. Eur J Med Chem  2018","journal-title":"Eur J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/10426507.2021.1972299","volume":"196","author":"Dawbaa Sam","year":"2021","unstructured":"Dawbaa Sam; Evren Asaf Evrim; Canturk Zerrin; Yurttas Leyla; Synthesis of new thiazole derivatives and evaluation of their antimicrobial and cytotoxic activities. Phos sul sil rel ele  2021,196(12),1093-1102","journal-title":"Phos sul sil rel ele"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","volume":"17","author":"Winer A.","year":"2018","unstructured":"Winer A.; Adams S.; Mignatti P.; Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes. Mol Cancer Ther  2018,17(6),1147-1155","journal-title":"Mol Cancer Ther"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2174\/1871520616666160802113620","volume":"17","author":"Kaplancikli Z.A.","year":"2017","unstructured":"Kaplancikli Z.A.; Alt\u0131ntop M.D.; Atli O.; Sever B.; Baysal M.; Temel H.E.; Demirci F.; Ozdemir A.; Synthesis and evaluation of a new series of thiazole derivatives as potential antitumor and MMP inhibitors. Anticancer Agents Med Chem  2017,17(5),674-681","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/16583655.2022.2135805","volume":"16","author":"Aljohani G.F.","year":"2022","unstructured":"Aljohani G.F.; Abolibda T.Z.; Alhilal M.; Al-Humaidi J.Y.; Alhilal S.; Ahmed H.A.; Gomha S.M.; Novel thiadiazole-thiazole hybrids: synthesis, molecular docking, and cytotoxicity evaluation against liver cancer cell lines. J Taibah Univ Sci  2022,16(1),1005-1015","journal-title":"J Taibah Univ Sci"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2147\/DDDT.S291579","volume":"15","author":"Sobhi M.","year":"2021","unstructured":"Sobhi M.; Thiazole-based thiosemicarbazones: synthesis, cytotoxicity evaluation and molecular docking study. Drug Des Devel Ther  2021,15,659-677","journal-title":"Drug Des Devel Ther"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.3390\/molecules27144639","volume":"27","author":"Sobhi M.","year":"2022","unstructured":"Sobhi M.; Synthesis, Molecular Docking Study, and Cytotoxic Activity against MCF Cells of New Thiazole-Thiophene Scaffolds. Molecules  2022,27(14),4639","journal-title":"Molecules"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3390\/sym14091814","volume":"14","author":"Al-Warhi T.","year":"2022","unstructured":"Al-Warhi T.; Abualnaja M.; Abu Ali O.A.; Alyamani N.M.; Elsaid F.G.; Shati A.A.; Albogami S.; Fayad E.; Abu Almaaty A.H.; Mohamed K.O.; Alamoudi W.M.; Zaki I.; Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition. Symmetry (Basel)  2022,14(9),1814","journal-title":"Symmetry (Basel)"},{"key":"ref=67","author":"Carmen Avendano J.","year":"2015","unstructured":"Carmen Avendano J.; Anticancer agents that modulate hormone action. Carlos Menendez  2015","journal-title":"Carlos Menendez"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.bmc.2018.02.048","volume":"26","author":"Sahin Z.","year":"2018","unstructured":"Sahin Z.; Ertas M.; Berk B.; Biltekin S.N.; Yurttas L.; Demirayak S.; Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl\/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives. Bioorg Med Chem  2018,26(8),1986-1995","journal-title":"Bioorg Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1700272","DOI":"10.1002\/ardp.201700272","volume":"351","author":"Ertas M.","year":"2018","unstructured":"Ertas M.; Sahin Z.; Berk B.; Yurttas L.; Biltekin S.N.; Demirayak S.; Pyridine\u2010substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation. Arch Pharm (Weinheim)  2018,351(3-4),1700272","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.taap.2017.06.003","volume":"329","year":"2017","unstructured":"Anti-liver cancer activity in vitro and in vivo induced by 2-pyridyl-2,3-thiazole deivatives. Toxicol Appl Pharmacol  2017,329,212-223","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejmech.2017.12.038","volume":"145","author":"Xie W.","year":"2018","unstructured":"Xie W.; Wu Y.; Zhang J.; Mei Q.; Zhang Y.; Zhu N.; Liu R.; Zhang H.; Design, synthesis and biological evaluations of novel pyridone-thiazole hybrid molecules as antitumor agents. Eur J Med Chem  2018,145,35-40","journal-title":"Eur J Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2174\/1570180817999201022192937","volume":"18","author":"Evren A.E.","year":"2021","unstructured":"Evren A.E.; Yurtta\u015f L.; Ekselli B.; Aksoy O.; Akalin-\u00c7ift\u00e7i G.; Design and efficient synthesis of novel 4,5-dimethyl thiazole- hydrazine derivatives and their anticancer activity. Lett Drug Des Discov  2021,18(4),372-386","journal-title":"Lett Drug Des Discov"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"102914","DOI":"10.1016\/j.arabjc.2020.11.020","volume":"14","author":"Alqahtani A.M.","year":"2021","unstructured":"Alqahtani A.M.; Bayazeed A.A.; Synthesis and antiproliferative activity studies of new functionalized pyridine linked thiazole derivatives. Arab J Chem  2021,14(1),102914","journal-title":"Arab J Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.3390\/molecules27196219","volume":"27","author":"Ivasechko I.","year":"2022","unstructured":"Ivasechko I.; Yushyn I.; Roszczenko P.; Senkiv J.; Finiuk N.; Lesyk D.; Holota S.; Czarnomysy R.; Klyuchivska O.; Khyluk D.; Kashchak N.; Gzella A.; Bielawski K.; Bielawska A.; Stoika R.; Lesyk R.; Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer Agents. Molecules  2022,27(19),6219","journal-title":"Molecules"},{"key":"ref=75","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4301910","author":"Zhang Z-H.","year":"2018","unstructured":"Zhang Z-H.; Wu H-M.; Deng S-N.; Cai X-Y.; Yao Y.; Design, synthesis and anticancer activities of novel 2-amino-4-phenyl thiazole scaffold containing amide moieties. J Chem  2018","journal-title":"J Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/1570180814666170704143015","volume":"15","author":"Wang H.","year":"2018","unstructured":"Wang H.; Cai Z.; Zheng S.; Ma H.; Lin H.; Zheng X.; Design, synthesis and biological evaluation of some novel thiazole-2-carboxamide derivatives as antitumor agents. Lett Drug Des Discov  2018,15(4),388-397","journal-title":"Lett Drug Des Discov"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/cbdd.13068","volume":"91","author":"Xu R.","year":"2018","unstructured":"Xu R.; Tian Y.; Huang S.; Yu J.; Deng Y.; Zhan M.; Zhang T.; Wang F.; Zhao L.; Chen Y.; Synthesis and evaluation of novel thiazole\u2010based derivatives as selective inhibitors of DNA\u2010binding domain of the androgen receptor. Chem Biol Drug Des  2018,91(1),172-180","journal-title":"Chem Biol Drug Des"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2174\/1570179414666161116123839","volume":"14","author":"Sobhi M.","year":"2017","unstructured":"Sobhi M.; Synthesis, molecular docking and anticancer evaluation of new arylazothiazoles. Curr Org Synth  2017,14(4),620-631","journal-title":"Curr Org Synth"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00044-018-2136-6","volume":"27","author":"Krzysztof Z.","year":"2018","unstructured":"Krzysztof Z.; Synthesis, molecular docking, ctDNA interaction, DFT calculation and evaluation of antiproliferative and anti-toxosplasma gondii activities of 2,4- diaminotriazine-thiazole derivatives. Med Chem Res  2018,27,1131-1148","journal-title":"Med Chem Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1570180814666171003145227","volume":"15","author":"Erguc A.","year":"2018","unstructured":"Erguc A.; Altintop M.D.; Atli O.; Sever B.; Iscan G.; Gormus G.; Ozdemir A.; Synthesis and biological evaluation of new quinoline- based thiazolyl hydrazine derivatives as potent antifungal and anticancer agents. Lett Drug Des Discov  2018,15(2),193-202","journal-title":"Lett Drug Des Discov"},{"key":"ref=81","first-page":"1","author":"Ramirez H.","year":"2021","unstructured":"Ramirez H.; Fernandez E.; Rodrigues J.; Mayora S.; Martinez G.; Celis C.; De Sanctis J.B.; Mijares M.; Charris J.; Synthesis and antimalarial and anticancer evaluation of 7-chloroquinoline-4-thiazoleacetic derivatives containing aryl hydrazide moieties. ARCHPHARM  2021,1-11","journal-title":"ARCHPHARM"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1590\/S1984-82502016000200008","volume":"52","author":"Braga S.F.P.","year":"2016","unstructured":"Braga S.F.P.; Fonseca N.C.; Ramos J.P.; Souza-Fagundes E.M.; Oliveira R.B.; Synthesis and cytotoxicity evaluation of thiosemicarbazones and their thiazole derivatives. Braz J Pharm Sci  2016,52(2),299-308","journal-title":"Braz J Pharm Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/md14120226","volume":"14","author":"Span\u00f2 V.","year":"2016","unstructured":"Span\u00f2 V.; Attanzio A.; Cascioferro S.; Carbone A.; Montalbano A.; Barraja P.; Tesoriere L.; Cirrincione G.; Diana P.; Parrino B.; Synthesis and antitumor activity of new thiazole nortopsentin analogs. Mar Drugs  2016,14(12),226","journal-title":"Mar Drugs"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2015.07.010","volume":"100","author":"Roskoski R.","year":"2015","unstructured":"Roskoski R.; A historical overview of protein kinases and their targeted small molecule inhibitors. Pharmacol Res  2015,100,1-23","journal-title":"Pharmacol Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ejmech.2017.06.052","volume":"138","author":"Parrino B.","year":"2017","unstructured":"Parrino B.; Attanzio A.; Span\u00f2 V.; Cascioferro S.; Montalbano A.; Barraja P.; Tesoriere L.; Diana P.; Cirrincione G.; Carbone A.; Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues. Eur J Med Chem  2017,138,371-383","journal-title":"Eur J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/embo-reports\/kvf094","volume":"3","author":"Benhar M.","year":"2002","unstructured":"Benhar M.; Engelberg D.; Levitzki A.; ROS, stress\u2010activated kinases and stress signaling in cancer. EMBO Rep  2002,3(5),420-425","journal-title":"EMBO Rep"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1871520616666160622095406","volume":"17","author":"Mukund P.","year":"2017","unstructured":"Mukund P.; A facile and microwave-assisted rapid synthesis of 2-arylamino-4-(3\u2032-indolyl)-thiazole as apoptosis inducing cytotoxic agents. Anticancer Agents Med Chem  2017,17(3),442-455","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/bcr3374","volume":"15","author":"Hunt K.K.","year":"2013","unstructured":"Hunt K.K.; Wingate H.; Yokota T.; Liu Y.; Mills G.B.; Zhang F.; Fang B.; Su C.H.; Zhang M.; Yi M.; Keyomarsi K.; Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Res  2013,15(1),R3","journal-title":"Breast Cancer Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3892\/or.17.1.161","volume":"17","author":"Wada Y.","year":"2007","unstructured":"Wada Y.; Yoshida K.; Tsutani Y.; Shigematsu H.; Oeda M.; Sanada Y.; Suzuki T.; Mizuiri H.; Hamai Y.; Tanabe K.; Ukon K.; Hihara J.; Neutrophil elastase induces cell proliferation and migration by the release of TGF-\u03b1, PDGF and VEGF in esophageal cell lines. Oncol Rep  2007,17(1),161-167","journal-title":"Oncol Rep"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"104819","DOI":"10.1016\/j.bioorg.2021.104819","volume":"110","author":"Donarska B.","year":"2021","unstructured":"Donarska B.; \u015awitalska M.; P\u0142azi\u0144ski W.; Wietrzyk J.; \u0141\u0105czkowski K.Z.; Effect of the dichloro-substitution on antiproliferative activity of phthalimide-thiazole derivatives. Rational design, synthesis, elastase, caspase 3\/7, and EGFR tyrosine kinase activity and molecular modeling study. Bioorg Chem  2021,110,104819","journal-title":"Bioorg Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"34044","DOI":"10.1021\/acsomega.3c05038","volume":"8","author":"Al-Humaidi J.Y.","year":"2023","unstructured":"Al-Humaidi J.Y.; Gomha S.M.; Riyadh S.M.; Ibrahim M.S.; Zaki M.E.A.; Abolibda T.Z.; Jefri O.A.; Abouzied A.S.; Synthesis, biological evaluation, and molecular docking of novel azolylhydrazonothiazoles as potential anticancer agents. ACS Omega  2023,8(37),34044-34058","journal-title":"ACS Omega"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"Falkenberg K.J.","year":"2014","unstructured":"Falkenberg K.J.; Johnstone R.W.; Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov  2014,13(9),673-691","journal-title":"Nat Rev Drug Discov"},{"key":"ref=93","first-page":"1114","volume":"16","author":"Moustafa T.","year":"2017","unstructured":"Moustafa T.; Microwave-assisted synthesis and antitumor evaluation of a new series of thiazolyl coumarin derivatives. EXCLI J  2017,16,1114-1131","journal-title":"EXCLI J"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/1570180813666161026153743","volume":"14","author":"Khaled R.A.","year":"2017","unstructured":"Khaled R.A.; Design, Synthesis, Antioxidant and Anticancer Activity of New Coumarin Derivatives Linked with Thiazole, Isoxazole or Pyrazole Moiety. Let Drug Desg Disc  2017,14(9),733-781","journal-title":"Let Drug Desg Disc"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.14233\/ajchem.2019.22106","volume":"31","author":"Brindha J.","year":"2019","unstructured":"Brindha J.; Fen Reji T.F.A.; Synthesis and molecular docking studies of coumarinyl thiazole as cell division protein kinase 2 inhibitor. Asian J Chem  2019,31(11),2453-2456","journal-title":"Asian J Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/molecules28020689","volume":"28","author":"Abolibda T.Z.","year":"2023","unstructured":"Abolibda T.Z.; Fathalla M.; Farag B.; Zaki M.E.A.; Gomha S.M.; Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase. Molecules  2023,28(2),689","journal-title":"Molecules"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7124\/bc.00094B","volume":"33","author":"Finiuk N.S.","year":"2017","unstructured":"Finiuk N.S.; Hreniuh V.P.; Ostapiuk Y.V.; Matiychuk V.S.; Frolov D.A.; Obushak M.D.; Stoika R.S.; Babsky A.M.; Antineoplastic activity of novel thiazole derivatives. Biopolim Kletka  2017,33(2),135-146","journal-title":"Biopolim Kletka"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2174\/1871520620666200824100408","volume":"21","author":"Zeyt\u00fcn E.","year":"2021","unstructured":"Zeyt\u00fcn E.; Alt\u0131ntop M.D.; Sever B.; \u00d6zdemir A.; Ellakwa D.E.; Ocak Z.; Ciftci H.I.; Otsuka M.; Fujita M.; Radwan M.O.; A new series of antileukemic agents: Design, synthesis, in-vitro and in-silico evaluation of thiazole- based ABL1 Kinase inhibitors. Anticancer Agents Med Chem  2021,21(9),1099-1109","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2174\/1871520618666180328115314","volume":"18","author":"Yurtta\u015f L.","year":"2018","unstructured":"Yurtta\u015f L.; Demir B.; \u00c7ift\u00e7i G.A.; Some thiazole derivatives combined with different heterocycles: Cytotoxicity evaluation and apoptosis inducing agents. Anticancer Agents Med Chem  2018,18(8),1115-1121","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejmech.2019.05.006","volume":"175","author":"Piechowska K.","year":"2019","unstructured":"Piechowska K.; \u015awitalska M.; Cytarska J.; Jaroch K.; \u0141uczykowski K.; Cha\u0142upka J.; Wietrzyk J.; Misiura K.; Bojko B.; Kruszewski S.; \u0141\u0105czkowski K.Z.; Discovery of tropinone-thiazole derivatives as potent caspase 3\/7 activators, and noncompetitive tyrosinase inhibitors with high antiproliferative activity: Rational design, one-pot tricomponent synthesis, and lipophilicity determination. Eur J Med Chem  2019,175,162-171","journal-title":"Eur J Med Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00044-020-02590-9","volume":"29","author":"Suma V.R.","year":"2020","unstructured":"Suma V.R.; Sreenivasulu R.; Rao M.V.B.; Subramanyam M.; Ahsan M.J.; Alluri R.; Rao K.R.M.; Design, synthesis, and biological evaluation of chalcone-linked thiazole-imidazopyridine derivatives as anticancer agents. Med Chem Res  2020,29(9),1643-1654","journal-title":"Med Chem Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4103\/1735-5362.323912","volume":"16","author":"Rahmani Khajouei M.","year":"2021","unstructured":"Rahmani Khajouei M.; Khodarahmi G.; Ghaderi A.; Synthesis and cytotoxic evaluation of some novel 3-[2-(2-phenyl-thiazol-4-yl)-ethyl]-3H-pyrido[2,3-d]pyrimidin-4-one derivatives. Res Pharm Sci  2021,16(5),455-463","journal-title":"Res Pharm Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1016\/j.bmcl.2016.10.015","volume":"26","author":"Lu H.","year":"2016","unstructured":"Lu H.; Rogowskyj J.; Yu W.; Venkatesh A.; Khan N.; Nakagawa S.; Goossens N.; Koh A.P.; Higashi T.; Gunasekaran G.; Schwarz M.E.; Hiotis S.P.; Xu X.; Kinney W.; Hoshida Y.; Block T.; Cuconati A.; Du Y.; Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agents. Bioorg Med Chem Lett  2016,26(23),5819-5824","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.06.015","author":"Ayati A.","year":"2018","unstructured":"Ayati A.; Bakhshaiesh T.O.; Moghimi S.; Esmaeili R.; Synthesis and biological evaluation of new coumarin bearing 2,4-diaminothiazole-5-carbonyl moiety. Eur J Med Chem  2018","journal-title":"Eur J Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13065-018-0439-9","volume":"12","author":"Yasser H.","year":"2018","unstructured":"Yasser H.; A facile synthesis, and antimicrobial and anticancer activities of some pyridines, thioamides, thiazole, urea, quinazoline, \u03b2-naphthyl carbamate, and pyrano[2,3-d]thiazole derivatives. Chem Cent J  2018,12(1),70","journal-title":"Chem Cent J"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"e01255","DOI":"10.1016\/j.heliyon.2019.e01255","volume":"5","author":"Santosh R.","year":"2019","unstructured":"Santosh R.; Prabhu A.; Selvam M.K.; Krishna P.M.; Nagaraja G.K.; Rekha P.D.; Design, synthesis, and pharmacology of some oxadiazole and hydroxypyrazoline hybrids bearing thiazoyl scaffold: antiproliferative activity, molecular docking and DNA binding studies. Heliyon  2019,5(2),e01255","journal-title":"Heliyon"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbcan.2010.04.004","volume":"1806","author":"Guo S.","year":"2010","unstructured":"Guo S.; Colbert L.S.; Fuller M.; Zhang Y.; Gonzalez-Perez R.R.; Vascular endothelial growth factor receptor-2 in breast cancer. Biochimica et Biophysica Acta (BBA)- Rev Can  2010,1806(1),108-121","journal-title":"Biochimica et Biophysica Acta (BBA)- Rev Can"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bioorg.2018.12.040","volume":"85","author":"Tahia K.","year":"2019","unstructured":"Tahia K.; Synthesis, anticancer effect and molecular modelling of new thiazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis. Bioorg Chem  2019,85,253-273","journal-title":"Bioorg Chem"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","volume":"17","author":"Du Z.","year":"2018","unstructured":"Du Z.; Lovly C.M.; Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer  2018,17(1),58","journal-title":"Mol Cancer"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"111648","DOI":"10.1016\/j.ejmech.2019.111648","volume":"182","author":"Sever B.","year":"2019","unstructured":"Sever B.; Alt\u0131ntop M.D.; Radwan M.O.; \u00d6zdemir A.; Otsuka M.; Fujita M.; Ciftci H.I.; Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors. Eur J Med Chem  2019,182,111648","journal-title":"Eur J Med Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2174\/1570180815666180731122118","volume":"16","author":"Evren A.E.","year":"2019","unstructured":"Evren A.E.; Yurtta\u015f L.; Eksell\u0131 B.; Akal\u0131n-C\u0131ftc\u0131 G.; Novel tri-substituted thiazoles bearing piperazine ring: Synthesis and evaluation of their anticancer activity. Lett Drug Des Discov  2019,16(5),547-555","journal-title":"Lett Drug Des Discov"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3390\/molecules26061705","volume":"26","author":"Huda R.M.","year":"2021","unstructured":"Huda R.M.; Synthesis, molecular docking studies and insilico ADMET screening of new heterocycles linked thiazole conjugates as potent anti-hepatic cancer agents. Molecules  2021,26,1705","journal-title":"Molecules"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1080\/10406638.2021.1939067","volume":"42","author":"Bandaru C.M.","year":"2022","unstructured":"Bandaru C.M.; Poojith N.; Jadav S.S.; Basaveswara Rao M.V.; Babu K.S.; Sreenivasulu R.; Alluri R.; Design, synthesis, anticancer evaluation and molecular docking studies of thiazole-pyrimidine linked amide derivatives. Polycycl Aromat Compd  2022,42(8),5368-5384","journal-title":"Polycycl Aromat Compd"}],"container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680096375796250610065705","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/242876\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680096375796250610065705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:44:42Z","timestamp":1791877482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/242876\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115680096375796250610065705","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-12-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}